高流量鼻导管与传统氧疗在支气管镜检查高危患者中的比较:随机对照试验方案
本研究为在中国四家学术中心开展的随机对照试验方案,拟纳入低氧血症、高碳酸血症、病态肥胖及气道狭窄等高危因素患者,在经鼻支气管镜检查期间分别接受高流量鼻导管(HFNC)或传统氧疗(COT)。主要结局为检查期间SpO2<90%持续10秒的低氧血症发生率,次要结局包括治疗升级需求与不良事件。
要点
- 研究纳入低氧血症、高碳酸血症、病态肥胖及气道狭窄等高危因素患者。
- HFNC组初始流量50 L/min、FIO2 0.45,可耐受时最高增至60 L/min;COT组经传统鼻导管给氧6 L/min。
- 主要结局为支气管镜检查期间SpO2<90%持续10秒的低氧血症发生率。
核心结论
- 作者试图证明HFNC可能降低高危患者支气管镜检查期间低氧血症的发生概率,结果将通过同行评议期刊及国内外会议传播。
研究设计与样本
- 随机对照试验方案,将在中国四家学术中心实施。
- 纳入具有低氧血症、高碳酸血症、病态肥胖及气道狭窄等高危因素的患者,在支气管镜检查期间使用HFNC或COT。
主要发现
- HFNC组初始气体流量设为50 L/min、吸入氧浓度(FIO2)为0.45,患者可耐受时流量最多可增至60 L/min;COT组经传统鼻导管给氧,氧流量设为6 L/min。
- 预氧合5分钟后经鼻置入支气管镜,持续监测生命体征、氧合(SpO2)及经皮二氧化碳(PtCO2)。
- 主要结局为支气管镜检查期间SpO2<90%持续10秒的低氧血症发生率,次要结局包括治疗升级需求与不良事件。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: High-flow nasal cannula (HFNC) has been proven to improve oxygenation and avoid intubation in hypoxemic patients. It has also been utilized during endoscopy examination to reduce the incidence of hypoxia. However, little is known about the effects of HFNC versus conventional oxygen therapy (COT) on oxygenation during bronchoscopy examination via nasal route; particularly, no study has compared the use of HFNC with that of COT at similar FIO2 for patients who have high-risk factors of desaturation during bronchoscopy examination. METHODS AND ANALYSIS: This randomized controlled trial will be implemented in four academic centers in China. Patients who have high-risk factors including hypoxemia, hypercapnia, morbid obesity, and narrow airway will be enrolled to use HFNC or COT during bronchoscopy examination. In the HFNC group, the initial gas flow will be set at 50 L/min with a fraction of inspired oxygen (FIO2) at 0.45, if the patient tolerates, the flow can be increased to 60L/min at most, while in the COT group, oxygen flow will be set at 6 L/min via a conventional nasal cannula. After 5 min pre-oxygenation, the bronchoscope will be inserted via the nasal route. Vital signs, oxygenation (SpO2), and transcutaneous CO2 (PtCO2) will be continuously monitored. The primary outcome is the incidence of hypoxemia, defined as SpO2 < 90% for 10 s during bronchoscopy examination, and secondary outcomes include the need for treatment escalation and adverse events. DISCUSSION: Hypoxia is a common complication of bronchoscopy, our study attempted to demonstrate that HFNC may reduce the probability of hypoxia during bronchoscopy in high-risk patients. The results will be disseminated through peer-reviewed journals and national and international conferences. TRIAL REGISTRATION: http://www.chictr.org.cn/ : ChiCTR2100055038. Registered on 31 December 2021.
引用
- Qin H, Jing GQ, Tan W, et al. Comparison of high-flow nasal cannula and conventional oxygen therapy for high-risk patients during bronchoscopy examination: protocol for a randomized controlled trial. Trials. 2023. PMID: 36604711. doi:10.1186/s13063-022-07001-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。